autonomic neuropathy is damage to the small, unmyelinated or thinly myelinated peripheral nerve fibers that carry autonomic (involuntary) signals to and from the heart, blood vessels, gastrointestinal tract, bladder, sweat glands, and eyes. It is a peripheral, fiber-level process, which distinguishes it from autonomic dysfunction, the broader umbrella term that also includes central (brainstem/hypothalamic) and neurotransmitter-mediated causes. Mechanistically, chronic hyperglycemia, abnormal protein deposition, or autoimmune attack causes progressive axonal degeneration of small autonomic C-fibers, disrupting the reflex arcs that normally regulate heart rate variability, vascular tone, and glandular secretion.
The most common etiologic subtype is diabetic autonomic neuropathy (E08-E13 with .43), followed by amyloid neuropathy (E85.1) and idiopathic peripheral autonomic neuropathy (G90.0-). It can be purely peripheral (length-dependent, as in diabetes) or part of a diffuse systemic small-fiber process (as in amyloidosis or paraneoplastic syndromes). It is commonly confused with autonomic dysfunction, for which it is the peripheral nerve-fiber subset, and with somatic peripheral neuropathy, which affects motor and sensory rather than involuntary visceral nerves.
Neuropathy entered English in the 1880s as neuropathy (noun), from Greek neuron (“nerve”) + pathos (“suffering”), literally “nerve disease.”Autonomic was coined around 1900 by physiologist John Newport Langley from Greek autonomos (“self-governing,” from autos “self” + nomos “law”). The root path- (“suffering, disease”) connects NEUROPATHY to the entire -pathy root family: myopathy (muscle disease), nephropathy (kidney disease), and retinopathy (retinal disease). The combining form neur- is highly productive in medical terminology and also appears in neuralgia, neuritis, neurogenic bladder, and neurology.
🔀 ALIASES / ALTERNATE TERMS
Diabetic autonomic neuropathy (DAN)(most common etiologic subtype; especially cardiovascular and genitourinary presentations — E08-E13 with .43)
Cardiovascular autonomic neuropathy (CAN)(subtype affecting heart rate variability and orthostatic blood pressure control; a documented complication requiring the diabetic manifestation code)
Peripheral autonomic neuropathy(used interchangeably; emphasizes the peripheral nerve fiber location of the damage)
Amyloid neuropathy(etiologic subtype from amyloid protein deposition in peripheral nerves; E85.1)
Small fiber neuropathy(clinical/lay term for damage limited to small unmyelinated autonomic and pain fibers; often overlaps with autonomic neuropathy on skin biopsy findings)
Autonomic neuropathy in diseases classified elsewhere(manifestation code used when the underlying systemic disease is coded first; G99.0)
Alcoholic autonomic neuropathy(etiologic subtype due to chronic alcohol-related nerve degeneration — coded outside the G90 family per Excludes1 note; G31.2)
Gastroparesis(gastrointestinal manifestation of autonomic neuropathy, especially diabetic; coded separately as K31.84)
Neurogenic bladder(genitourinary manifestation of autonomic neuropathy; N31.9)
🔗 RELATED TERMS
autonomic dysfunction — the broader umbrella term for any disruption of autonomic regulation, whether peripheral (neuropathic), central, or neurotransmitter-mediated; autonomic neuropathy is its peripheral nerve-fiber subset
peripheral neuropathy — damage to somatic (motor/sensory) peripheral nerves rather than autonomic fibers; the two frequently coexist in diabetes and amyloidosis but are coded and staged separately
diabetic peripheral neuropathy — the somatic counterpart often documented alongside autonomic neuropathy in diabetic patients; coded with its own .40-series combination code
gastroparesis — delayed gastric emptying from vagal (autonomic) nerve damage; a common diabetic autonomic neuropathy manifestation; K31.84
orthostatic hypotension — the cardiovascular sign most associated with cardiovascular autonomic neuropathy; I95.1
Apoptosis — programmed cell death implicated in progressive small-fiber loss in chronic autonomic neuropathies
amyloidosis — systemic protein deposition disease that causes amyloid neuropathy when peripheral nerves are infiltrated; E85.1
Sudomotor — adjective for sympathetic fibers controlling sweat glands; damage produces the anhidrosis seen in advanced autonomic neuropathy; tested via CPT 95923
Nerve conduction study (NCS) — electrodiagnostic test primarily assessing large myelinated somatic fibers; does not directly measure small autonomic fiber function but is often ordered alongside autonomic testing to rule out mixed neuropathy; CPT 95907
Testing of autonomic nervous system function; cardiovagal innervation (parasympathetic function), including 2 or more of the following: heart rate response to deep breathing with recorded R-R interval, Valsalva ratio, and 30:15 ratio
Testing of autonomic nervous system function; vasomotor adrenergic innervation (sympathetic adrenergic function), including beat-to-beat blood pressure and R-R interval changes during Valsalva maneuver and at least 5 minutes of passive tilt
Testing of autonomic nervous system function; sudomotor, including 1 or more of the following: quantitative sudomotor axon reflex test (QSART), silastic sweat imprint, thermoregulatory sweat test, and changes in sympathetic skin potential
Testing of autonomic nervous system function; combined parasympathetic and sympathetic adrenergic function testing with at least 5 minutes of passive tilt
Unlisted neurological or neuromuscular diagnostic procedure (used for automated/portable autonomic testing devices; replaced deleted code 95943)
⚠️ Coding Note:Diabetic autonomic neuropathy is a combination code (E08-E13 with .43) — always sequence the diabetes code first per ICD-10-CM convention, and never additionally assign a standalone G90 code for the same diabetic manifestation, since that constitutes double-coding the same clinical event. Watch for documentation that says “autonomic neuropathy” without stating a cause: on an inpatient profee claim this defaults to the vague G90.09, so if diabetes, amyloidosis, or chronic alcohol use is anywhere in the chart, query the provider to link the neuropathy to its underlying disease — the linked combination code carries far more clinical specificity and often more CC/MCC weight than the idiopathic default. Amyloid neuropathy requires two codes: the E85 amyloidosis code plus G99.0 as the manifestation code, sequenced per the “code first underlying disease” instruction under G99.0. Remember the Type 1 Excludes note under G90 — autonomic dysfunction due to alcohol is never coded to G90; it goes to G31.2 instead, and using both together is an audit flag. For your urology caseload, neurogenic bladder (N31.9/N31.8) frequently appears as the presenting manifestation of underlying diabetic or idiopathic autonomic neuropathy — code the neuropathy in addition to the bladder dysfunction when both are documented and clinically evaluated during the stay, not just the symptom alone.